These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8775843)

  • 1. Testing medications for the treatment of addiction in pregnancy: one reviewer's opinion.
    Wright C
    NIDA Res Monogr; 1995; 149():231-5. PubMed ID: 8775843
    [No Abstract]   [Full Text] [Related]  

  • 2. Overview: medications development for the treatment of drug abuse.
    Vocci F; Chiang CN; Cummings L; Hawks R
    NIDA Res Monogr; 1995; 149():4-15. PubMed ID: 8775832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Expert Advisory Committee on the Use of Drugs in the Treatment of Abuse and Dependence to Narcotic and Controlled Drugs.
    CMAJ; 1990 Nov; 143(9):861-5. PubMed ID: 2224712
    [No Abstract]   [Full Text] [Related]  

  • 4. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    Toll L; Berzetei-Gurske IP; Polgar WE; Brandt SR; Adapa ID; Rodriguez L; Schwartz RW; Haggart D; O'Brien A; White A; Kennedy JM; Craymer K; Farrington L; Auh JS
    NIDA Res Monogr; 1998 Mar; 178():440-66. PubMed ID: 9686407
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
    Heidbreder CA; Hagan JJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Illicit use of clonidine in opiate-abusing pregnant women.
    Anderson F; Paluzzi P; Lee J; Huggins G; Svikis D
    Obstet Gynecol; 1997 Nov; 90(5):790-4. PubMed ID: 9351766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Substitution therapy with buprenorphine to pregnant women with opioid dependency].
    Olofsson MJ; Ege PP
    Ugeskr Laeger; 2003 Sep; 165(38):3605. PubMed ID: 14556389
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of drug dependence.
    Mitcheson M
    Practitioner; 1983 Jan; 227(1375):127-37. PubMed ID: 6844227
    [No Abstract]   [Full Text] [Related]  

  • 10. [Buprenorphine as opioid substitution to pregnant addicts].
    Rasmussen ET; Nielsen LB
    Ugeskr Laeger; 2003 Sep; 165(38):3607-8. PubMed ID: 14556390
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic considerations for the design and screening of potential medications.
    DeVane CL
    NIDA Res Monogr; 1995; 149():116-29. PubMed ID: 8775838
    [No Abstract]   [Full Text] [Related]  

  • 12. Perinatal drug and alcohol addiction: the role of the primary care provider.
    Donaldson PL
    Lippincotts Prim Care Pract; 2000; 4(3):349-58. PubMed ID: 11271133
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy and birth under maintenance treatment with diamorphine (heroin): a case report.
    Hartwig C; Haasen C; Reimer J; Garbe W; Lichtermann D; Wuellenweber L; Dilg C
    Eur Addict Res; 2008; 14(2):113-4. PubMed ID: 18334822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of opiate addiction during pregnancy.
    Sloan D; O'Connor J
    Ir Med J; 1998; 91(5):164, 166. PubMed ID: 9973750
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interdisciplinary therapeutic approaches with substance abusers taking into consideration gender differences].
    Fischer G; Eder H
    Wien Med Wochenschr; 1999; 149(11):331-6. PubMed ID: 10544458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
    Fiellin DA
    Top HIV Med; 2004; 12(3):77-82. PubMed ID: 15310938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conceptual basis of replacement therapies for chemical dependence.
    Jasinski DR; Henningfield JE
    Prog Clin Biol Res; 1988; 261():13-34. PubMed ID: 3289002
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacotherapeutic environments for substance use disorders.
    Gardner TJ; Kosten TR
    Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.